Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Seeger

Showing results (141-150 of 266) with videos related to

Pageof 27
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1986
Amplification units containing human N-myc and c-myc genesK W Kinzler, B A Zehnbauer, G M Brodeur, et al.
Science (New York, N.Y.)|May 9, 1986
Identification and characterization of the protein encoded by the human N-myc oncogeneD J Slamon, T C Boone, R C Seeger, et al.
Annals of Surgical Oncology|November 1, 1995
Pelvic neuroblastoma--implications for a new favorable subgroup: a Children's Cancer Group experienceG M Haase, M C O'Leary, D O Stram, et al.
Progress in Clinical and Biological Research|January 1, 1988
Characterization of human neuroblastoma cell lines that lack N-myc gene amplificationR K Wada, R C Seeger, G M Brodeur, et al.
Journal of Pediatric Hematology/Oncology|March 7, 2002
Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell lineC P Anderson, R C Seeger, N Satake, et al.
Cancer|August 30, 2000
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodularS Umehara, A Nakagawa, K K Matthay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2001
Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cellsL S Metelitsa, O V Naidenko, A Kant, et al.
Cancer|December 1, 1993
Human neuroblastoma cell lines that express N-myc without gene amplificationR K Wada, R C Seeger, G M Brodeur, et al.
Clinical and Experimental Immunology|October 1, 1976
Severe combined immunodeficiency with B lymphocytes: in vitro correction of defective immunoglobulin production by addition of normal T lymphocytesR C Seeger, R A Robins, R H Stevens, et al.
Cancer Research|June 1, 1985
Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experienceH W Hann, A E Evans, S E Siegel, et al.
Pageof 27

Showing results (141-150 of 266) with videos related to

Sort By:
Pageof 27
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1986
Amplification units containing human N-myc and c-myc genesK W Kinzler, B A Zehnbauer, G M Brodeur, et al.
Science (New York, N.Y.)|May 9, 1986
Identification and characterization of the protein encoded by the human N-myc oncogeneD J Slamon, T C Boone, R C Seeger, et al.
Annals of Surgical Oncology|November 1, 1995
Pelvic neuroblastoma--implications for a new favorable subgroup: a Children's Cancer Group experienceG M Haase, M C O'Leary, D O Stram, et al.
Progress in Clinical and Biological Research|January 1, 1988
Characterization of human neuroblastoma cell lines that lack N-myc gene amplificationR K Wada, R C Seeger, G M Brodeur, et al.
Journal of Pediatric Hematology/Oncology|March 7, 2002
Buthionine sulfoximine and myeloablative concentrations of melphalan overcome resistance in a melphalan-resistant neuroblastoma cell lineC P Anderson, R C Seeger, N Satake, et al.
Cancer|August 30, 2000
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodularS Umehara, A Nakagawa, K K Matthay, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 7, 2001
Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cellsL S Metelitsa, O V Naidenko, A Kant, et al.
Cancer|December 1, 1993
Human neuroblastoma cell lines that express N-myc without gene amplificationR K Wada, R C Seeger, G M Brodeur, et al.
Clinical and Experimental Immunology|October 1, 1976
Severe combined immunodeficiency with B lymphocytes: in vitro correction of defective immunoglobulin production by addition of normal T lymphocytesR C Seeger, R A Robins, R H Stevens, et al.
Cancer Research|June 1, 1985
Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experienceH W Hann, A E Evans, S E Siegel, et al.
Pageof 27